Possibility of Drug-Drug Interaction through Prescription Analysis at the National Institute of Cardiovascular Disease (NICVD), Bangladesh

Q: What is the clinical evidence from this study?

Study design: Observational. Population: Cardiovascular diseases (n=100). Intervention: Cardiovascular and non-cardiovascular drug co-prescription. Primary outcome: Incidence of potential drug-drug interactions (DDI).

Abu Yousuf

doi:10.17352/ojpp.000004

December 30, 2016Open Journal of Pharmacology and PharmacotherapeuticsOpen Access

Possibility of Drug-Drug Interaction through Prescription Analysis at the National Institute of Cardiovascular Disease (NICVD), Bangladesh

View Full Paper

Ask AI

Bookmark

Share

Study Design

Type

Observational (n=100)

Randomization

Random selection of prescriptions

Multicenter

No

PICO

P

Population

100 inpatients aged 45 to 67 years with cardiovascular diseases at a single center in Bangladesh whose prescriptions were analyzed for potential drug-drug interactions.

E

Exposure / Comparator

Cardiovascular and non-cardiovascular drug co-prescription

O

Primary Outcome

Incidence of potential drug-drug interactions (DDI)

Limitations

Small sample size of 100 prescriptions
Single-center study
Drug interactions were identified by mechanism of action rather than clinical occurrences

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Introduction: Medicaments are the ultimate choice of treatment when lifestyle and diet changes are unable to serve the preventive strategy for cardiovascular diseases. Contradictorily, detrimental Drug–Drug Interactions (DDI) between cardiovascular drugs with the non-cardiovascular drugs may lead to alterations in the therapeutic responses, and pose a grave health concern leading to early morbidity and mortality.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Abu Yousuf (2016) conducted an observational in Cardiovascular diseases (n=100). Cardiovascular and non-cardiovascular drug co-prescription was evaluated on Incidence of potential drug-drug interactions (DDI).

synapsesocial.com/papers/6a6f2813660549caf2c3b4c9 https://doi.org/10.17352/ojpp.000004

View Full Paper

Ask AI

Bookmark

Share

Possibility of Drug-Drug Interaction through Prescription Analysis at the National Institute of Cardiovascular Disease (NICVD), Bangladesh

Study Design

PICO

Limitations

Ask about this paper

Abstract

Discussion

Cite This Study

Possibility of Drug-Drug Interaction through Prescription Analysis at the National Institute of Cardiovascular Disease (NICVD), Bangladesh

Study Design

PICO

Limitations

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading